Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
Keywords:
Tags: Pharmaceutical,
Grouped Articles
Lilly Plans to Lay Off 30% of Its Sales Reps
Wall Street Journal 04/12/2013
Eli Lilly's Drug Assembly Line
BusinessWeek 02/25/2010
Eli Lilly Enters Unusual Patent Dispute
Wall Street Journal 08/18/2013
Rivals Threaten to Crowd Out Novo in Expanding Diabetes Market
Wall Street Journal 08/25/2013
Eli Lilly, Unlike Rivals, Isn't Pulling Back on R&D
Wall Street Journal 10/21/2013
Lilly Diabetes Drug Ruled Comparable to Market Leader
Wall Street Journal 02/25/2014
Grouped Articles
Lilly Plans to Lay Off 30% of Its Sales Reps
Wall Street Journal 04/12/2013
Eli Lilly's Drug Assembly Line
BusinessWeek 02/25/2010
Eli Lilly Enters Unusual Patent Dispute
Wall Street Journal 08/18/2013
Rivals Threaten to Crowd Out Novo in Expanding Diabetes Market
Wall Street Journal 08/25/2013
Eli Lilly, Unlike Rivals, Isn't Pulling Back on R&D
Wall Street Journal 10/21/2013
Eli Lilly Sets Plans for Emerging Markets
Wall Street Journal 06/08/2010
Grouped Articles
Putting Eli Lilly’s Biotech Bounce to the Test
Wall Street Journal 07/20/2015
Why Lilly’s Pipeline Worries Aren’t Over
Wall Street Journal 10/13/2015
Eli Lilly: Why Earnings Guidance Takes a Back Seat
Wall Street Journal 01/06/2016
Grouped Articles
Eli Lilly, Unlike Rivals, Isn't Pulling Back on R&D
Wall Street Journal 10/21/2013
Lilly Diabetes Drug Ruled Comparable to Market Leader
Wall Street Journal 02/25/2014
Lilly Joins With Chinese Biotech to Develop, Market Cancer Drugs
Wall Street Journal 03/20/2015
Putting Eli Lilly’s Biotech Bounce to the Test
Wall Street Journal 07/20/2015
Why Lilly’s Pipeline Worries Aren’t Over
Wall Street Journal 10/13/2015
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1